DK0785196T3 - Polymorfer A og B af 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazin - Google Patents

Polymorfer A og B af 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazin

Info

Publication number
DK0785196T3
DK0785196T3 DK95913177T DK95913177T DK0785196T3 DK 0785196 T3 DK0785196 T3 DK 0785196T3 DK 95913177 T DK95913177 T DK 95913177T DK 95913177 T DK95913177 T DK 95913177T DK 0785196 T3 DK0785196 T3 DK 0785196T3
Authority
DK
Denmark
Prior art keywords
diphenylmethyl
dioxolan
polymorphs
phenyl
piperazine
Prior art date
Application number
DK95913177T
Other languages
English (en)
Inventor
Ambros Rafael Foguet
Burniol Lluis Anglada
Hernandez Jose A Ortiz
Munoz Aurelio Sacristan
Barenys Josep Maria Castello
Carreno Manuel Mauricio Raga
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Application granted granted Critical
Publication of DK0785196T3 publication Critical patent/DK0785196T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95913177T 1995-03-28 1995-03-28 Polymorfer A og B af 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazin DK0785196T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES1995/000033 WO1996030366A1 (es) 1995-03-28 1995-03-28 Polimorfos a y b de 1-(difenilmetil)-4-[3-(2-fenil-1,3-dioxolan-2-il)propil]piperazina

Publications (1)

Publication Number Publication Date
DK0785196T3 true DK0785196T3 (da) 2000-10-16

Family

ID=8289110

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95913177T DK0785196T3 (da) 1995-03-28 1995-03-28 Polymorfer A og B af 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazin

Country Status (14)

Country Link
US (1) US5852021A (da)
EP (1) EP0785196B1 (da)
JP (1) JPH10501555A (da)
KR (1) KR970703337A (da)
AT (1) ATE194004T1 (da)
AU (1) AU690974B2 (da)
DE (1) DE69517593T2 (da)
DK (1) DK0785196T3 (da)
ES (1) ES2149353T3 (da)
FI (1) FI964653A7 (da)
GR (1) GR3034463T3 (da)
NO (1) NO965050L (da)
PT (1) PT785196E (da)
WO (1) WO1996030366A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES514340A0 (es) * 1982-06-17 1983-09-01 Ferrer Int "procedimiento de obtencion de nuevos derivados de piperazina".

Also Published As

Publication number Publication date
AU690974B2 (en) 1998-05-07
US5852021A (en) 1998-12-22
AU2074095A (en) 1996-10-16
GR3034463T3 (en) 2000-12-29
FI964653L (fi) 1996-11-21
WO1996030366A1 (es) 1996-10-03
FI964653A0 (fi) 1996-11-21
JPH10501555A (ja) 1998-02-10
NO965050D0 (no) 1996-11-27
FI964653A7 (fi) 1996-11-21
EP0785196B1 (en) 2000-06-21
DE69517593D1 (de) 2000-07-27
DE69517593T2 (de) 2001-03-08
ES2149353T3 (es) 2000-11-01
EP0785196A1 (en) 1997-07-23
KR970703337A (ko) 1997-07-03
PT785196E (pt) 2000-12-29
NO965050L (no) 1996-11-27
ATE194004T1 (de) 2000-07-15

Similar Documents

Publication Publication Date Title
BR9611436A (pt) D-tartarato de (-)-cis-6(s)-fenil-5(r)-[4-(2-pirrolidin-1-iletóxi) fenil]-5,6,7,8,-tetra-hidronaftalen-2-ol
ATE188691T1 (de) 1-(1,2-disubstituierte piperidinyl)-4- substituierte piperazin derivate
TR199600438A2 (tr) Piperazin türevleri.
FI960364A7 (fi) Uusia 1,4-(difenyylialkyyli)piperatsiinijohdoksia
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
FI932173A7 (fi) 4-(1,2-bentsisoksatsolyyli)piperidiiniantipsykoottisia aineita
FI945086A7 (fi) 1-(2H-1-bentsopyran-2-oni-8-yyli)piperatsiinijohdannaisia
FI834807A7 (fi) 1-cyklopropyl-6-fluor- 1,4-dihydro-4- oxo-7-/4-(oxoalkyl)-1-piperazinyl/-3- kinolinkarboxylsyror och deras derivat, foerfarande foer deras framstaellning och dessa innehaollande antibakteriella medel.
DK0785196T3 (da) Polymorfer A og B af 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazin
FI852423L (fi) 1-(bis-(4-fluorofenyl)-metyl)- 4-(3-fenyl-2-propenyl)-hexahydro-1h-1,4-diazepin med kalciumantagonistverkan, dess framstaellning och kompositioner innehaollande densamma.
AR227542A1 (es) Procedimiento para preparar derivados de 4-(4-amino-6,7-dimetoxi-quinazolin-2-il)-1-(2,4-dioxo-2,2,3,4-tetrahidro-pirimidin-6-il)-piperazina
ATE177788T1 (de) Eukaryotisches expressionssystem
FI923723A0 (fi) 4-(4-(4-4-hydroxifenyl)-1 -piperazinyl)fenyl)-5-metyl-3h-1,2,4-triazol-3-on derivat.
JPS56138170A (en) 2-(1-piperazinyl)-2,4,6-cycloheptatriene-1-one derivative
ES538242A0 (es) Un procedimiento de preparar un derivado de 4,5-dihidro-6-(2-(4-(1h-imidazol-1-il)-fenil)-alquilenil o alquilen-3(2h)-piridazinona.
DK0975601T3 (da) Fremgangsmåde til fremstilling af butylthio-isoquinolin og mellemprodukter derfor
ES493888A0 (es) Un metodo de preparar derivados de piperidina
MX9203166A (es) 1-[(2-fluorofenil) (4-fluorofenil)fenilmetil]-ih-imidazol.
MX9203684A (es) Benzotiazepinas.
DE69735341D1 (de) Benzo(b)thiophenderivate, Zwischenprodukte, Zubereitungen und Verfahren
FI964114L (fi) Uusia 1-(5-metaanisulfonamidoindolyyli-2-karbonyyli)-4-(3-(1-metyylietyyliamino)-2-pyridinyyli)piperatsiinin kiteisiä muotoja
NL190929C (nl) 1-(Difenylmethyl)-4-(1,3-dioxolan-2-yl)-4-fenylbutylpiperazine, werkwijze voor de bereiding ervan alsmede farmaceutisch preparaat.
DK0761657T3 (da) Fremgangsmåde til fremstilling af benzylsubstituerede rhodaninderivater
FI960615A7 (fi) 1-(2-(substituoitu-vinyyli))-5H-2,3-bentsodiatsepiinijohdannaiset
DK189185D0 (da) (6,11-dihydro-11-oxodibenz(b,e)oxepinyl)-pentanoler, deres fremstilling og anvendelse